Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Methodology Identifies Cause of Outbreak

By LabMedica International staff writers
Posted on 22 Oct 2012
Genotyping has been used identify the source of a hematology clinic outbreak of Mycobacterium mucogenicum, a gram-positive, acid-fast bacteria found in tap water.

The use of repetitive sequence-based polymerase chain reaction system enabled the identification of M. More...
mucogenicum in a water sample from an examination-room faucet with an aerator, which has the same bacteria as the infected patients.

Scientists at the East Carolina University (Greenville, NC, USA) collected water samples from two faucets in the examination rooms and performed an audit of infection control practices, including hand hygiene compliance, use of appropriate techniques for injections, and other procedures. The outbreak involved four young sickle cell patients and all four patients had long-term lines implanted to deliver medication into the bloodstream. They were probably exposed to M. mucogenicum during outpatient visits when the lines were accessed. All four developed blood cultures positive for M. mucogenicum in May or June 2008.

A healthcare worker prepared injections at the sink counter during the period of infection. It is likely that the fluid bag being used to prepare injections became contaminated when the worker washed her hands. The four patient isolates and the tap water isolate from the room with the aerator were found to have greater than 98.5% similarity. The source of the M. mucogenicum bacteremia outbreak in the clinic tap water supply was identified by the Diversilab genotyping analysis (bioMérieux, Marcy l'Etoile, France). The preparation of intravenous medications near the sink was likely an important factor in transmission, along with the presence of a faucet aerator.

Muhammad Salman Ashraf, MD, assistant professor at The Brody School of Medicine at East Carolina University, said, "This study demonstrates the efficacy of using genotyping technology in identifying the source of the outbreak. But it also points to the need for proper infection control practice in clinic settings, and that faucet aerators should be avoided in all healthcare facilities, especially those caring for immunosuppressed patients." The study was published online on September 19, 2012, in the journal Infection Control and Hospital Epidemiology.

Related Links:

East Carolina University
bioMérieux



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.